Barrow, Hanley, Mewhinney & Strauss’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,972
Closed -$16.2K 372
2025
Q1
$16.2K Hold
1,972
﹤0.01% 170
2024
Q4
$16.3K Buy
1,972
+300
+18% +$2.41K ﹤0.01% 182
2024
Q3
$12.8K Buy
1,672
+1,354
+426% +$12.5K ﹤0.01% 202
2024
Q2
$3.29K Buy
318
+1
+0.3% +$11 ﹤0.01% 256
2024
Q1
$3.79K Sell
317
-2
-0.6% -$22 ﹤0.01% 246
2023
Q4
$3.44K Buy
319
+88
+38% +$1.07K ﹤0.01% 250
2023
Q3
$3.2K Buy
+231
New +$3.38K ﹤0.01% 247
2023
Q2
Sell
-295
Closed -$3.45K 304
2023
Q1
$3.45K Buy
+295
New +$4.31K ﹤0.01% 240
2022
Q1
Sell
-3,127
Closed -$26K 334
2021
Q4
$26K Buy
+3,127
New +$26.9K ﹤0.01% 286
2021
Q3
Sell
-2,070
Closed -$21K 338
2021
Q2
$21K Buy
+2,070
New +$17.5K ﹤0.01% 290

Other funds holding PTEN

Barrow, Hanley, Mewhinney & Strauss's PTEN Position: Q2 2025 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of Patterson-UTI (PTEN) in Q2 2025, closing a stake of 1,972 shares — an estimated $16.2K sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in PTEN in Q2 2021 and held it in 10 quarters. The position peaked at $26K in Q4 2021. 361 funds tracked by Wall St. Rank hold PTEN as of Q2 2025.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining Patterson-UTI position as of Q2 2025 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 1,972 Patterson-UTI shares in Q2 2025, an estimated $16.2K.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Patterson-UTI in Q2 2021 and held it in 10 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's Patterson-UTI position peaked at $26K in Q4 2021.
  • 361 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2025.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2025, filed 12 Aug 2025.